020sek
0,0 %
Date:2025-05-13Time:18:00:00Latest report:Q1-2025List:First NorthTicker:ACARIX
Market Cap:229 msekEnterprise Value:184 msekNet Sales:6,38 msekEarnings:-65,4 msekEmployees:0ISIN:SE0009268717

Ratios

10-year key figure history for Acarix turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Acarix with index and moving average MA50 and MA200.

Stockprice:0,20
MA50:0,23
MA200:0,28
Price/MA200:-28,4 %
RSI (14):43,4
Price/MA50:-10,4 %

Description

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.

Medical Equipment